પ્રોક્ટર અને ગેમ્બલ હેલ્થ શેરની કિંમત

P&G હેલ્થ એક અગ્રણી વૈશ્વિક હેલ્થકેર કંપની છે, જે ઓવર-ધ-કાઉન્ટર દવાઓ અને ડાયેટરી સપ્લીમેન્ટ સહિત કન્ઝ્યુમર હેલ્થ પ્રૉડક્ટમાં નિષ્ણાત છે. નવીનતા અને ગુણવત્તા પર ધ્યાન કેન્દ્રિત કરીને, તેનો હેતુ વિશ્વભરમાં વ્યક્તિઓ અને પરિવારોની સુખાકારીને વધારવાનો છે.

Procter & Gamble Health has an operating revenue of Rs. 1,159.74 Cr. on a trailing 12-month basis. An annual revenue de-growth of -6% needs improvement, Pre-tax margin of 24% is great, ROE of 37% is exceptional. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading close to its 50DMA and comfortably placed above its 200DMA, around 5% above 200DMA. It needs to take support around the 50 DMA level to continue further upside move. It has recently broken out of a base in its weekly chart and is trading around -2% from the pivot point (which is the ideal buying range for a stock). From an O'Neil Methodology perspective, the stock has an EPS Rank of 39 which is a POOR score indicating inconsistency in earnings, a RS Rating of 48 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B which is evident from recent demand for the stock, Group Rank of 50 indicates it belongs to a fair industry group of Medical-Generic Drugs and a Master Score of C is fair but needs to improve. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

ડિસ્ક્લેમર: આ સ્ટૉક એનાલિસિસ રિપોર્ટ માત્ર માહિતીના હેતુઓ માટે અલ્ગોરિધમ રૂપે બનાવવામાં આવે છે અને તેને ખરીદ અથવા વેચાણની ભલામણ તરીકે ગણવામાં આવશે નહીં.